We are live on
!
Find out more
Fayez Sarofim & Co Portfolio holdings
AUM
$39.1B
1-Year Est. Return
15.14%
This Fund
S&P 500
This Quarter
Est. Return
+5.48%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$39.3B
AUM Growth
+$2.28B
(+6.1%)
Cap. Flow
+$591M
Cap. Flow
% of AUM
1.5%
Top 10 Holdings %
Top 10 Hldgs %
42.96%
Holding
292
New
14
Increased
87
Reduced
79
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$208M |
| 2 |
NVIDIA
NVDA
|
+$141M |
| 3 |
Icon
ICLR
|
+$117M |
| 4 |
Amazon
AMZN
|
+$59.1M |
| 5 |
ASML
ASML
|
+$50.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$146M |
| 2 |
Chubb
CB
|
+$99.6M |
| 3 |
HES
Hess
HES
|
+$53.1M |
| 4 |
Air Products & Chemicals
APD
|
+$45.9M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.48% |
| 2 | Financials | 17.99% |
| 3 | Healthcare | 13.14% |
| 4 | Consumer Staples | 11.72% |
| 5 | Energy | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Tapestry
TPR
$31.4B
| $931K | ﹤0.01% |
19,810
| – | – |
|
177
Kimberly-Clark
KMB
$35.7B
| $926K | ﹤0.01% |
6,507
| – | – |
|
178
MPLX
MPLX
$59.8B
| $925K | ﹤0.01% |
20,814
| – | – |
|
179
Edwards Lifesciences
EW
$51.1B
| $922K | ﹤0.01% |
13,965
| – | – |
|
180
Martin Marietta Materials
MLM
$32.6B
| $903K | ﹤0.01% |
1,677
-658
| -28% | -$356K |
|
181
Unilever
UL
$137B
| $860K | ﹤0.01% |
11,766
| – | – |
|
182
Hancock Whitney
HWC
$6.26B
| $836K | ﹤0.01% |
16,347
| – | – |
|
183
NRG Energy
NRG
$29.2B
| $833K | ﹤0.01% |
9,147
-200
| -2% | -$15.9K |
|
184
Northrop Grumman
NOC
$77.9B
| $832K | ﹤0.01% |
1,576
| – | – |
|
185
Dell
DELL
$277B
| $824K | ﹤0.01% |
6,954
| – | – |
|
186
Crane Co
CR
$12.7B
| $807K | ﹤0.01% |
5,099
| – | – |
|
187
GE HealthCare
GEHC
$31.5B
| $800K | ﹤0.01% |
8,525
-50
| -0.6% | -$4.2K |
|
188
Palo Alto Networks
PANW
$283B
| $796K | ﹤0.01% |
4,660
-250
| -5% | -$42.1K |
|
189
InterContinental Hotels
IHG
$23.5B
| $781K | ﹤0.01% |
7,065
| – | – |
|
190
Stryker
SYK
$131B
| $780K | ﹤0.01% |
2,160
| – | – |
|
191
Ball Corp
BALL
$17.3B
| $740K | ﹤0.01% |
10,900
| – | – |
|
192
Campbell Soup
CPB
$6.67B
| $739K | ﹤0.01% |
15,100
| – | – |
|
193
Williams Companies
WMB
$86.1B
| $734K | ﹤0.01% |
16,085
| – | – |
|
194
Pool Corp
POOL
$7.11B
| $733K | ﹤0.01% |
1,946
| – | – |
|
195
Salesforce
CRM
$152B
| $724K | ﹤0.01% |
2,646
| – | – |
|
196
Energy Transfer Partners
ET
$69.8B
| $707K | ﹤0.01% |
44,056
| – | – |
|
197
Eagle Materials
EXP
$6.59B
| $698K | ﹤0.01% |
2,425
| – | – |
|
198
Carlisle Companies
CSL
$14.8B
| $695K | ﹤0.01% |
1,545
-636
| -29% | -$263K |
|
199
NextEra Energy
NEE
$181B
| $692K | ﹤0.01% |
8,185
| – | – |
|
200
DuPont de Nemours
DD
$19.1B
| $681K | ﹤0.01% |
6,090
+842
| +16% | +$85.8K |
|
Similar funds
HF
Fayez Sarofim & Co's Q3 2024 Portfolio in Review
As of Q3 2024, Fayez Sarofim & Co held 292 positions worth $39.3B, up 6.1% from $37.1B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Fayez Sarofim & Co's Q3 2024 filing shows 14 new, 87 increased, 79 reduced and 7 closed positions. Its largest new stake was General Motors: 8,584 shares worth $385K. The largest sale was Comcast, an estimated $146M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Fayez Sarofim & Co's largest Q3 2024 buy was General Motors: 8,584 shares worth $385K.
- Fayez Sarofim & Co added most to Microsoft in Q3 2024, an estimated $208M increase.
- Fayez Sarofim & Co's biggest Q3 2024 reduction was Comcast, cutting an estimated $146M.
- Fayez Sarofim & Co fully exited Gilead Sciences in Q3 2024, selling an estimated $323K.
- Fayez Sarofim & Co's ten largest holdings make up 43% of its $39.3B portfolio in Q3 2024.
- Fayez Sarofim & Co opened 14 new positions and closed 7 in Q3 2024.
- Fayez Sarofim & Co's portfolio value rose 6.1% quarter-over-quarter to $39.3B.
Based on Fayez Sarofim & Co's 13F filing for Q3 2024, filed 14 Nov 2024.